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It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
Canonical Wnt 
signaling and 
cystogenesis
Cystic diseases of the kidney are often 
due to mutations of ciliary proteins 
and are associated with abnormal cell 
proliferation. Since cilia are involved 
in signaling pathways, it had been sug-
gested that the mutations in these pro-
teins may cause abnormal proliferation, 
which is necessary for cyst formation. 
One such ciliary protein, Inv, acts as 
a switch between canonical and non-
canonical signaling, and hence its muta-
tion may activate canonical signaling by 
b-catenin. In testing this hypothesis, 
Sugiyama et al. found that cystogenesis 
was actually developing before prolif-
eration, thereby showing that canonical 
Wnt signal is not involved in cysto-
genesis. See page 957.
Regulatory T-cell 
promotion in  
chronic rejection
In their study of ongoing allo immune 
response,  Tsaur et  al .  generated 
allopeptide-specific T cells from 
patients with biopsy-proven chronic 
rejection. Numbers of CD4+CD25+ 
regulatory T cells (Tregs) were found to 
be higher in those whose allograft dys-
function was stable than in those with 
unstable function. A higher percentage 
of Tregs was found in patients with sta-
ble graft function on tacrolimus-based 
compared with cyclosporine-based 
treatment. Patients with stable graft 
function had a significantly higher 
expression of interleukin (IL)-4 and 
IL-10, whereas the cytokines IL-2, 
IL-17, and interferon-g were signifi-
cantly higher in patients with allograft 
dysfunction in vitro. Hence, adjustment 
of immunosuppression to promote 
naturally occurring Tregs may be use-
ful in treatment with chronic rejection. 
See page 1005.
Deterring transplant 
tourism
Transplant tourism remains a global 
concern. As they report in this issue, 
Gill et al. studied 93 patients who 
received transplants outside Canada. 
They found that the majority were eth-
nic minorities who went to their country 
of origin, where many of them received 
a preemptive transplant very early in 
their disease course. All who completed 
the evaluation had been on waiting 
lists in Canada. Most had a potential 
living donor, albeit that some of these 
donors would not be medically suitable, 
for reasons including ABO incompat-
ibility. These findings highlight the 
need for more aggressive attempts to 
educate patients with chronic kidney 
disease well before they reach the stage 
at which renal replacement therapy is 
needed. See page 1026.
